MRPL38

Large ribosomal subunit protein mL38 · Q96DV4 · MRPL38 on Sugi Atlas →

0 patent compounds predicted against MRPL38, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MRPL38 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea PHASE3COMPLETED
Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma PHASE2COMPLETED
LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy People EARLY_PHASE1COMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma nanRECRUITING
Choroid Plexus Dysfunction in Neurological Diseases nanRECRUITING
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Phenotype and Etiology of Pallister-Hall Syndrome nanCOMPLETED
Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) nanACTIVE_NOT_RECRUITING
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Gene Expression in Inflammatory Bowel Disease nanENROLLING_BY_INVITATION
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment nanUNKNOWN
Institution of an Italian Registry and Biobank for Biological Sample Collection nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Molecular Analysis of Microphthalmia/Anophthalmia nanCOMPLETED
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants nanCOMPLETED
Exercise-induced Epigenetic Adaptations nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a MRPL38 binder may also engage these)

ProteinNameSimilarity
Q8K2M0 1.000 Q8K2M0 →
Q5RDL7 1.000 Q5RDL7 →
Q3ZBF3 1.000 Q3ZBF3 →
Q5PQN9 0.999 Q5PQN9 →
Q9BQ95 0.981 Q9BQ95 →
Q4R5Q4 0.980 Q4R5Q4 →
Q5XIC2 0.977 Q5XIC2 →
O94810 0.976 O94810 →
Q58DQ5 0.976 Q58DQ5 →
D3ZND0 0.976 D3ZND0 →
Q9QZH6 0.976 Q9QZH6 →
Q3SX05 0.976 Q3SX05 →
Q16586 0.975 Q16586 →
Q9D479 0.974 Q9D479 →
Q0V9C9 0.974 Q0V9C9 →
Q2KHV9 0.974 Q2KHV9 →
O75064 0.974 O75064 →
Q562C2 0.973 Q562C2 →
Q09200 0.973 Q09200 →
Q99N84 0.973 Q99N84 →
Q91WR3 0.973 Q91WR3 →
Q10468 0.972 Q10468 →
Q8C6B2 0.972 Q8C6B2 →
AMPD2 AMP deaminase 2 0.972 landscape →
Q96I76 0.972 Q96I76 →
Q5EA71 0.972 Q5EA71 →
Q5T011 0.972 Q5T011 →
O88496 0.972 O88496 →
Q8QZW3 0.972 Q8QZW3 →
Q924T7 0.972 Q924T7 →